14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

CYTR Predictions History

6 years ago
JS predicted that CYTR for 2017-05-24 is going $0.533 (-82.93%)

6 years ago
JuanC Villegas predicted that CYTR for 2017-05-24 is going $0.536 (-82.84%)

6 years ago
Topnotch.Node.7245 predicted that CYTR for 2017-05-23 is going $0.741 (-76.27%)

Rank:

6 years ago
JS predicted that CYTR for 2017-05-23 is going $0.575 (-82.46%)

6 years ago
Sycosys predicted that CYTR for 2017-05-23 is going $0.555 (-83.07%)

Rank:

6 years ago
JS predicted that CYTR for 2017-05-22 is going $0.530 (-83.00%)

6 years ago
RTBear predicted that CYTR for 2017-05-19 is going $0.510 (-83.00%)

Rank:

6 years ago
JS predicted that CYTR for 2017-05-16 is going $0.450 (-82.16%)

6 years ago
Sasha.Koniev.6963 predicted that CYTR for 2017-05-16 is going $0.420 (-83.84%)

Rank:

6 years ago
JS predicted that CYTR for 2017-05-15 is going $0.417 (-83.95%)

Click to get the best stock tips daily for free!

About CytRx Corporation

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and A... CYTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT